Product Information
AZASITE 1% EYE DROPS is a brand product labeled by Thea Pharma Inc., priced at $98.5088 per ML under NDC 82584030703. Its NADAC has been published 177 times since May 17, 2023.
FDA first approved this application on Apr 27, 2007.
The High Outlier badge above means this manufacturer's average price in the azithromycin monohydrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584030703
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN MONOHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA050810FDA Approved
4/27/2007
On Market Since
11/1/2022
Pharmacological Classes
Price Statistics
The NADAC for AZASITE 1% EYE DROPS has been published 177 times since May 17, 2023, and over the history we have for it it has risen 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $98.5088 per ML |
|---|---|
| All-time high | $98.9425 (Oct 16, 2024) |
| All-time low | $90.8608 (May 17, 2023) |
| 52-week high | $98.5088 |
| 52-week low | $98.3310 |
| Median price | $98.4195 |
| Average price | $96.3505 |
| Largest weekly change | +8.0% (May 8, 2024) |
| Weeks tracked | 177 |
| Tracking since | May 17, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azithromycin monohydrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Thea Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azithromycin monohydrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZASITE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for AZASITE 1% EYE DROPS, manufactured by Thea Pharma Inc., is $98.5088 per ML (NDC 82584030703), effective Sep 30, 2026.
How has the price of AZASITE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for AZASITE 1% EYE DROPS has risen 8.4%. It has been tracked across 177 weekly CMS publications since May 17, 2023.
What are the highest and lowest recorded NADAC prices for AZASITE 1% EYE DROPS?
Since May 17, 2023, the NADAC for AZASITE 1% EYE DROPS has ranged from a low of $90.8608 (May 17, 2023) to a high of $98.9425 (Oct 16, 2024), with a median of $98.4195 per ML.
Are there cheaper alternatives to AZASITE 1% EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of AZASITE 1% EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZASITE 1% EYE DROPS?
AZASITE 1% EYE DROPS (NDC 82584030703) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.